Gauzy Receives Nasdaq Notice for 2025 20-F Delay, Faces July 20 Cure Deadline
GAUZ•On May 19, 2026, Gauzy received a Nasdaq notice for non-compliance with Listing Rule 5250(c)(1) due to delayed filing of its 2025 Form 20-F. The company has 60 days until July 20 to submit a compliance plan to avoid delisting, with a potential extension to November 11.
1. Nasdaq Notice Details
On May 19, 2026, Gauzy received a letter from Nasdaq’s Listing Qualifications Department notifying the company of non-compliance with Listing Rule 5250(c)(1) for failing to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2025.
2. Cure Period and Compliance Plan
Under Nasdaq rules, the company has 60 calendar days from the notice date—until July 20, 2026—to submit a plan outlining steps to regain compliance. If accepted, Nasdaq may grant an extension through November 11, 2026, for the delayed filing.
3. Risk of Delisting and Market Impact
If Nasdaq rejects the compliance plan, Gauzy can appeal to a hearing panel, but failure to timely file the Form 20-F would trigger delisting procedures. While trading continues without immediate interruption, a non-compliance indicator will be broadcast, potentially affecting investor confidence.
